CYTOKINETICS, INCORPORATED Interest Receivable
CYTOKINETICS, INCORPORATED (CYTK) had Interest Receivable of $200.00 thousand as of 2016-12-31, per its 10-K filed 2017-03-06.
Discontinued › Balance Sheet › Assets
us-gaap:InterestReceivable · last filed 2017-03-06
- 2016-12-31: Interest Receivable $200.00K.
- 2015-12-31: Interest Receivable $200.00K; Interest Receivable as first filed $231.00K.
- 2014-12-31: Interest Receivable $109.00K.
- 2013-12-31: Interest Receivable $215.00K.
| Period end | Interest Receivable | Interest Receivable as first filed |
|---|---|---|
| 2016-12-31 | $200.00K 10-K · filed 2017-03-06 | |
| 2015-12-31 | $200.00K 10-K · filed 2017-03-06 | $231.00K 10-K · filed 2016-03-03 |
| 2014-12-31 | $109.00K 10-K · filed 2016-03-03 | |
| 2013-12-31 | $215.00K 10-K · filed 2015-03-06 | |
| 2012-12-31 | $187.00K 10-K · filed 2014-03-07 | |
| 2011-12-31 | $206.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |